XML 15 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Earnings - Unaudited - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Net sales $ 84,197 $ 120,684 $ 187,272 $ 238,308
Cost of goods sold 57,630 79,480 127,806 156,490
Gross margin 26,567 41,204 59,466 81,818
Selling, general and administrative expenses 14,668 17,036 31,427 34,597
Research and development expenses 5,522 6,257 12,930 13,048
Restructuring charges 135 911 375 2,995
Gain on sale of assets 0 (83) 0 (122)
Operating earnings 6,242 17,083 14,734 31,300
Other (expense) income:        
Interest expense (909) (467) (1,760) (933)
Interest income 304 440 635 872
Other (expense) income, net 256 (1,107) (1,726) (1,010)
Total other (expense) income. net (349) (1,134) (2,851) (1,071)
Earnings before income taxes 5,893 15,949 11,883 30,229
Income tax expense 1,036 4,006 3,218 6,867
Net earnings $ 4,857 $ 11,943 $ 8,665 $ 23,362
Earnings per share:        
Basic (in dollars per share) $ 0.15 $ 0.36 $ 0.27 $ 0.71
Diluted (in dollars per share) $ 0.15 $ 0.36 $ 0.27 $ 0.70
Basic weighted - average common shares outstanding (in shares): 32,262 32,799 32,364 32,803
Effect of dilutive securities (in shares) 242 406 284 422
Diluted weighted - average common shares outstanding (in shares) 32,504 33,205 32,648 33,225
Cash dividends declared per share (in dollars per share) $ 0.04 $ 0.04 $ 0.08 $ 0.08